Recent Financing
Recent Raise
52North Health is a University of Cambridge spin-out developing the Aster™ biomarker detection platform and Neutrocheck®, a rapid finger-prick blood test for triaging chemotherapy patients at risk of neutropenic sepsis.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at 52 North Health.